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Embolization of the first diagonal branch 
of the left anterior descending coronary artery 
as a porcine model of chronic trans-mural 
myocardial infarction
Derek W Hanes1†, Maelene L Wong1†, C W Jenny Chang1, Sterling Humphrey2, J Kevin Grayson3, Walter D Boyd2 
and Leigh G Griffiths1*
Abstract 
Background: Although the incidence of acute death related to coronary artery disease has decreased with the 
advent of new interventional therapies, myocardial infarction remains one of the leading causes of death in the US. 
Current animal models developed to replicate this phenomenon have been associated with unacceptably high mor-
bidity and mortality. A new model utilizing the first diagonal branch of the left anterior descending artery (D1-LAD) 
was developed to provide a clinically relevant lesion, while attempting to minimize the incidence of adverse compli-
cations associated with infarct creation.
Methods: Eight Yucatan miniature pigs underwent percutaneous embolization of the D1-LAD via injection of 90 µm 
polystyrene micro-spheres. Cardiac structure and function were monitored at baseline, immediately post-operatively, 
and at 8-weeks post-infarct using transthoracic echocardiography. Post-mortem histopathology and biochemical analy-
ses were performed to evaluate for changes in myocardial structure and extracellular matrix (ECM) composition respec-
tively. Echocardiographic data were evaluated using a repeated measures analysis of variance followed by Tukey’s HSD 
post hoc test. Biochemical analyses of infarcted to non-infarcted myocardium were compared using analysis of variance.
Results: All eight pigs successfully underwent echocardiography prior to catheterization. Overall procedural survival 
rate was 83% (5/6) with one pig excluded due to failure of infarction and another due to deviation from protocol. 
Ejection fraction significantly decreased from 69.7 ± 7.8% prior to infarction to 50.6 ± 14.7% immediately post-
infarction, and progressed to 48.7 ± 8.9% after 8-weeks (p = 0.011). Left ventricular diameter in systole significantly 
increased from 22.6 ± 3.8 mm pre-operatively to 30.9 ± 5.0 mm at 8 weeks (p = 0.016). Histopathology showed 
the presence of disorganized fibrosis on hematoxylin and eosin and Picro Sirius red stains. Collagen I and sulfated 
glycosaminoglycan content were significantly greater in the infarcted region than in normal myocardium (p = 0.007 
and p = 0.018, respectively); however, pyridinoline crosslink content per collagen I content in the infarcted region was 
significantly less than normal myocardium (p = 0.048).
Conclusion: Systolic dysfunction and changes in ECM composition induced via embolization of the D1-LAD closely 
mimic those found in individuals with chronic myocardial infarction (MI), and represents a location visible without the 
need for anesthesia. As a result, this method represents a useful model for studying chronic MI.
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Background
Coronary artery disease and subsequent myocardial 
infarction (MI) is the leading cause of cardiovascular 
morbidity and mortality in the United States, account-
ing for 1 in every 6 deaths [1]. Although advances in MI 
therapy have improved acute survival rates, survivors are 
prone to development of chronic degenerative changes as 
a result of irreversible myocyte loss, extracellular matrix 
(ECM) fibrosis, and pathological gene programing [2].
Numerous animal models have been developed in an 
attempt to study the molecular and cellular changes fol-
lowing MI, and to test novel therapies for prevention of 
chronic negative myocardial remodeling. Historically, 
dog, sheep, rodent, and rabbit models of MI have been 
described [3, 4]. More recently, porcine models have 
gained popularity due to greater similarity in coronary 
anatomy and cardiac physiology compared to humans. 
Additionally, the heart-to-body weight ratio of mini-pigs 
is very similar to that of humans [5]. Further, the larger 
size of swine, compared to alternative animal models, 
permits study of clinically relevant therapeutic modali-
ties, such as minimally invasive cardiac interventional 
procedures. Thus, porcine models have supplanted other 
animals in the recreation of the native diseases found in 
humans due to their closer similarity to human cardiac 
anatomy and pathophysiology.
Previously reported porcine MI models have been asso-
ciated with substantial challenges, which have limited 
their utility in assessment of therapeutic candidates. The 
most commonly used approaches to date have utilized 
surgical ligation [6–9] or coil embolization [10–12] of the 
left anterior descending (LAD) coronary artery, distal to 
the first and/or second diagonal branches as a standard 
for level of occlusion. Alternatively, ameroid constric-
tors [5], cryoinjury [13], ethanol infusion [14], autolo-
gous platelet embolization [3], balloon occlusion [15–17], 
and micro-bead LAD embolization [18] procedures have 
also been described. Regardless of the methodology used 
to achieve LAD occlusion, serious complications have 
arisen, including development of malignant ventricular 
arrhythmias [9, 15, 16], variability of infarct size and loca-
tion [5, 11], and high mortality rates. Additionally, gen-
eral anesthesia and expensive imaging modalities, such 
as magnetic resonance imaging (MRI) [19] or technetium 
single photon emission tomography (Tc-SPECT) [11] 
are required to visualize the infarcted territory due to 
the apical location of the distal LAD territory. Although 
transthoracic echocardiographic imaging is possible in 
sedated pigs, the apical location of infarcts produced in 
distal LAD occlusion models are poorly visualized with 
this modality. An ideal MI model should include the fol-
lowing criteria: (1) provide consistent lesion size and 
distribution, (2) result in an infarcted territory in an 
anatomical location amenable to imaging without the 
need for anesthesia, and (3) have low mortality rates.
The aims of the current study were to utilize the loca-
tion of the first diagonal branch of the LAD to create a 
porcine model of chronic MI that: (1) produces an infarc-
tion that models the cellular and molecular changes seen 
in humans with chronic, trans mural infarcts, (2) pro-
duces an infarcted area that can be visualized via stand-
ard echocardiography with greater than or equal to 20% 
reduction in left ventricular ejection fraction (LVEF), and 
(3) overcomes the adverse complications compared to 
those reported with previous MI models.
Methods
This study was performed at an Association for the 
Assessment and Accreditation of Laboratory Animal 
Care International-accredited large animal research 
facility, following approval by the Animal Care and Use 
Committee at David Grant USAF Medical Center, Travis 
Air Force Base, California. All animals received care and 
were used in strict compliance with the Guide for the 
Care and Use of Laboratory Animals [20].
Animal inclusion criteria
Eight intact female or castrated male Yucatan mini-pigs 
were obtained (S & S Farms, Ramona, CA, USA) and 
acclimated for at least 10 days before use. At the time of 
surgery, animals weighed between 43 and 66 kg and were 
approximately 4–5 months of age. All pigs were admin-
istered 75 mg clopidogrel bisulfate (Plavix, Bristol-Myers 
Squibb/Sanofi Pharmaceuticals Partnership, Bridgewa-
ter, NJ, USA), 325  mg aspirin, and 600  mg amiodarone 
hydrochloride (TEVA Pharmaceuticals USA, Sellersville, 
PA, USA) orally once daily for 2 days prior to, and on the 
morning of the procedure.
Anesthesia
Prior to surgery, each animal was fasted for 8–12 h with 
unlimited access to water. Animals were pre-medicated 
with 6.6  mg/kg tiletamine/zolazepam (Telazol, Fort 
Dodge Animal Health, Fort Dodge, IA, USA) intramus-
cularly (IM). Following isoflurane induction and endotra-
cheal intubation, balanced anesthesia was maintained 
with gaseous and intravenous agents. The gaseous anes-
thetic consisted of 1% sevoflurane in 100% oxygen [17]. 
Animals were mechanically ventilated with tidal vol-
umes of 7–10  mL/kg and a respiratory rate of 10–15 
breaths per minute sufficient to maintain end tidal CO2 
at 40 ± 5 mm Hg. Partial intravenous (IV) anesthesia was 
also performed using a composite mixture of 0.1 µg/kg/
min remifentanil hydrochloride (Ultiva, Mylan Institu-
tional LLC, Rockford, IL, USA), 5  µg/kg/min ketamine 
hydrochloride (Ketaset, Fort Dodge Animal Health, Fort 
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Dodge, IA, USA), and 0.25 µg/kg/min midazolam hydro-
chloride (West-Ward Pharmaceutical Corp., Eatontown, 
NJ, USA) added to 50  µg/kg/min propofol (Diprivan, 
APP Pharmaceuticals, LLC, Schaumburg, IL, USA) [21, 
22]. Two IV catheters were placed in marginal ear veins 
(or central venous access in the right jugular vein if ear 
catheterization could not be performed) for administra-
tion of fluids. Intravenous fluid administration with 0.9% 
saline and 5% dextrose in water containing heparin (200–
300  U/kg/h) was continued throughout the procedure. 
Additionally, 1 g cefazolin sodium (West-Ward Pharma-
ceutical Corp., Eatontown, NJ, USA) was given IV and 
2  mg/kg carprofen (Rimadyl, Zoetis, Inc., Kalamazoo, 
MI, USA) was given IM, prior to beginning the proce-
dure. Animals were monitored during general anesthe-
sia and in the immediate post-operative recovery period 
using continuous electrocardiography, direct blood pres-
sure, end-tidal CO2, inspired and expired inhalant anes-
thesia, SpO2, and temperature.
Anti‑arrhythmic/anticoagulant therapy
Intravenous amiodarone hydrochloride (Mylan Insti-
tutional LLC, Rockford, IL, USA) was administered as 
a 10–12  mg/kg bolus at the start of the procedure and 
maintained at 8–50 µg/kg/min throughout [4, 23]. Lido-
caine hydrochloride (Hospira Inc., Lakeforest, IL, USA) 
was administered as a 1–2 mg/kg bolus IV at the start of 
the procedure and continued as an intravenous infusion 
at 50–200 µg/kg/min during anesthesia. Atropine sulfate 
(West-Ward Pharmaceutical Corp., Eatontown, NJ, USA) 
was given at 0.01–0.05 mg/kg as needed for bradycardia.
Heparin sodium (Fresenius Kabi USA, Inc., Schaum-
burg, IL, USA) was given as a 200–300  U/kg bolus IV 
at the start of the procedure and continued at a rate of 
50–150  U/kg/h IV throughout. Activated clotting time 
(ACT) was assessed prior to heparin administration, fol-
lowed by every 30–45 min thereafter, with a goal of main-
taining ACT >300 s.
Myocardial infarction model
Animals were placed in dorsal recumbency and the 
inguinal area was aseptically prepared. The right femoral 
artery was identified, and a 21 G, 7 cm echogenic intro-
ducer needle (Arrow Intl.; Reading, PA, USA) was placed 
in the right femoral artery under ultrasound guidance. A 
0.018″ nitinol wire (AngioDynamics; Queensbury, NY, 
USA) was introduced through the needle. The introducer 
needle was removed and the wire exchanged for a 0.035″ 
guide wire using a standard micro-puncture sheath 
(AngioDynamics). A 7 Fr introducer sheath (Arrow 
Intl.) with side-port was advanced over the guide wire 
and sutured into position using 2-0 silk suture (Ethicon 
Inc., Somerville, NJ, USA). Blood pressure was directly 
monitored via a transducer connected to the side-port 
throughout the procedure.
A 6  Fr balloon wedge pressure catheter (Arrow Intl.) 
was introduced into the femoral artery and the balloon 
inflated. The catheter was advanced, under fluoroscopic 
guidance (OEC 9900 Elite; GE Healthcare; Princeton, 
NJ, USA), to the level of the descending thoracic aorta. 
A 0.035″ J-tipped exchange wire (Cook Medical; Bloom-
ington, IN, USA) was advanced through the balloon 
wedge pressure catheter to the level of the aortic arch 
and advanced into the common carotid artery, and the 
balloon catheter removed over-the-wire. A 6 Fr H-Stick 
catheter (Cordis VistaBrite; Miami Lakes, FL, USA) was 
advanced over-the-wire to the level of the ascending 
aortic arch and the exchange wire removed. The tip of 
the catheter was advanced into the ascending aorta and 
placed in the left coronary ostium. A coronary angiogram 
was performed by injection of 10 mL of dilute iodixanol 
(Visipaque; GE Healthcare, Princeton, NJ, USA), diluted 
50:50 with sterile saline, into the left main coronary 
artery (Figure 1). The H-stick catheter was advanced into 
the proximal LAD artery and angiography repeated to 
confirm the location of the first diagonal branch of the 
LAD (D1-LAD) using both ventrodorsal and lateral pro-
jections (Figure  1a, b, respectively). Nitroglycerin in 5% 
dextrose solution (Baxter Healthcare Corporation, Deer-
field, IL, USA) was administered in 40 µg boluses through 
the H-stick catheter to prevent coronary vasospasm as 
needed. A 0.014″ micro guide-wire (Cook Medical) was 
advanced through the H-Stick catheter and directed into 
the D1-LAD branch. Following placement of the micro 
guide-wire (Figure  1c), angiography was repeated to 
confirm placement in the D1-LAD (Figure 1d). A 2 mm 
coronary balloon catheter (Abbott Vascular; Santa Clara, 
CA, USA) was advanced over-the-wire into the proxi-
mal portion of the D1-LAD artery. The balloon catheter 
was inflated to 6–8  psi and occlusion of the artery was 
confirmed by S-T segment elevation on continuous elec-
trocardiography. Two mL of 90 µm diameter polystyrene 
micro-beads (Polybead, Polysciences, Inc., Warrington, 
PA, USA) was administered through the coronary bal-
loon catheter. Following micro-bead delivery, the balloon 
catheter was deflated and removed. Angiography was 
performed to confirm obstruction of the D1-LAD and 
the remaining catheters removed. The introducer sheath 
was also removed and hemostasis achieved using manual 
compression of the femoral artery.
Echocardiography
All echocardiography was performed at the right paraster-
nal location according to standard imaging techniques, [24] 
with a S5-1 linear probe (iE33 xMatrix Ultrasound, Philips 
Healthcare, Andover, MA, USA). Animals were imaged in 
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dorsal recumbency, under anesthesia (during MI) or heavy 
sedation (at 8-weeks post-MI). A standard left ventricu-
lar outflow tract view was used for both 2-D and M-mode 
assessment (Figure 2). All left ventricular dimensions were 
measured from M-mode images with the cursor perpen-
dicular to the interventricular septum at the level of the 
chordae (Figure 2c, d). Both 2D and M-mode images were 
obtained before and immediately after infarction, as well as 
at the 8-week endpoint. Three consecutive heart cycles were 
measured for each patient and all measurements averaged. 
LVEF was then calculated and expressed as a percentage.
Post‑operative course
Postoperatively, pigs were assessed daily by veterinary 
staff and were given 2–4  mg/kg carprofen (Rimadyl, 
Pfizer Animal Health, New York, NY, USA) orally twice 
daily for 2–3 days. Animals were subsequently monitored 
for any clinical signs of progression to congestive heart 
failure over the 8-week study period.
Gross necropsy and histopathology
Pigs were euthanized at 8-weeks post-MI with an over-
dose of pentobarbital/phenytoin solution (Beuthana-
sia-D Special, Schering-Plough Animal Health Corp; 
Union, NJ, USA). The heart was extirpated, and digital 
images were taken for later assessment of infarct size 
and location. The heart was subsequently grossly sec-
tioned to evaluate distribution of the infarcted region 
and wall thickness compared to non-infarcted myo-
cardium. Sectioned heart tissue samples were stored 
Figure 1 Left main coronary angiography and D1-LAD catheterization. Coronary angiography of the left main coronary artery in ventrodorsal (a) 
and lateral (b) projections. The left coronary anatomy, including left circumflex coronary (LCx) and left anterior descending (LAD) arteries is clearly 
visualized. The D1-LAD artery was identified and is shown outlined here by the arrows in the ventrodorsal and lateral views. Following identification 
of the D1-LAD artery, the artery was then catheterized with a 0.014″ micro-guide wire with correct wire positioning designated by arrows on lateral 
projection (c). Repeat angiography was performed following wire advancement (d) with the wire still present designated by the arrows.
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in 10% buffered formalin solution for 48 h followed by 
storage in 70% ethanol prior to paraffin embedding and 
histologic staining. Representative regions of infarcted 
myocardium were thin-sectioned and stained using 
hematoxylin and eosin stain to evaluate tissue architec-
ture and composition. Picro Sirius red stain was used to 
highlight collagen deposition associated with post-MI 
fibrosis. Verhoeff-Van Gieson (VVG) stained sections 
were also evaluated in order to assess changes in ECM 
composition at the infarcted region compared to nor-
mal myocardium.
Biochemical composition analysis
All chemicals were purchased from Sigma-Aldrich (St. 
Louis, MO, USA) unless otherwise stated. Circumferen-
tially oriented strips (approximately 1 cm × 1 cm × 7 cm) 
of porcine myocardium were taken from the left 
ventricular posterior wall and septum of each animal. 
A slice (approximately 3  mm  ×  1  cm  ×  1  cm) from 
the endocardial to epicardial wall of each strip was 
then trimmed into a set of four pieces (approximately 
2 mm × 3 mm × 1 cm), with each piece containing both 
endocardial and epicardial surfaces. Following determi-
nation of wet weight, samples were frozen at −20°C over-
night and lyophilized for 72  h before determination of 
dry weight. Lyophilized samples were processed accord-
ingly for quantitative biochemistry (n = 5 per group and 
assay).
Hydrochloric acid (5N) was added to one set of lyo-
philized samples at 200 µL per 10 mg wet weight (WW). 
Samples were incubated at 100°C for 36  h. Collagen 
content was quantified using a hydroxyproline assay kit 
(Chondrex Inc., Redmond, WA, USA) with a calibration 
curve of 5N hydrochloric acid digested porcine collagen 
Figure 2 Two-dimensional (2D) and M-mode echocardiography prior to and following D1-LAD occlusion. Echocardiography was performed prior 
to (a) and following D1-LAD occlusion. Occasionally, the presence of the infarct could be seen as a hyperechoic amorphous mass on 2D images, 
associated with the left ventricular posterior wall and anterolateral papillary muscle, shown here outlined by arrows (b). Compared to pre-MI 
M-mode images (c), there was an appreciable decrease in systolic excursion of the left ventricular posterior wall following D1-LAD occlusion (d). The 
double arrows represent the left ventricle at its maximal diastolic diameter, while the single arrows represent the maximal systolic excursion of the LV 
posterior wall.
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I standards (Chondrex, Inc.). Pyridinoline crosslink 
content was determined on high performance liquid 
chromatography (HPLC) using a calibration curve of 
pyridinoline standards (Quidel, San Diego, CA, USA) as 
described previously [25].
Papain extraction reagent (0.2  M sodium phosphate 
buffer, pH 6.4 containing 0.1 M sodium acetate, 0.01 M 
Na2EDTA, 0.005 M cysteine HCl, and 0.4 mg/mL papain) 
was added to one set of lyophilized samples at 200 µL per 
10 mg dry weight (DW). Samples were incubated at 65°C 
and 1,000 rpm for 24 h three times. Sulfated glycosami-
noglycan (GAG) content was quantified from pooled 
supernatant using the Blyscan sulfated GAG assay (Bio-
color Ltd., Carrickfergus, UK) and a calibration curve of 
GAG standards.
Statistical analysis
Echocardiographic data was tabulated and compared for 
each animal at each time point using a repeated measures 
analysis of variance (ANOVA). Values showing a signifi-
cant difference were subsequently analyzed using Tuk-
ey’s HSD post hoc test. Quantitative biochemical data 
for infarcted myocardium was compared to septum for 
each animal using Fit Least Squares. When differences 
were determined to be significant, Least Squares Means 
Students t test was performed. All other quantitative 
variables were compared between septum and infarcted 
myocardium using analysis of variance (ANOVA). Calcu-
lations were performed using JMP Pro 11 statistical soft-
ware (SAS Inst. Inc.) with statistical significance defined 
as p < 0.05.
Results
Viability and myocardial infarction reproducibility
All eight animals were anesthetized and successfully 
underwent echocardiography prior to percutaneous 
catheterization. The right femoral artery was successfully 
catheterized in all animals and the D1-LAD accessed. 
One pig developed a coronary artery dissection follow-
ing catheterization and was euthanized under anesthe-
sia, resulting in an 87.5% (7/8 pigs) acute procedural 
survival rate. Micro-bead delivery was not achieved in 
one pig due to clot formation in the balloon catheter. 
Consequently, this pig was excluded from echocardio-
graphic data analysis. Ultimately, a total of 6 of 8 pigs 
(75%) were successfully embolized and included in the 
post-embolization evaluation (n = 6). One pig died due 
to a deviation from protocol during the post-anesthesia 
recovery period, resulting in a total of five pigs (n = 5) for 
the chronic MI (8-week) comparison. Overall, procedural 
success rate at 8-weeks was therefore 71% (5/7 pigs) with 
one pig censored due to deviation from post-anesthetic 
recovery protocol. Overall procedural survival rate was 
83% (5/6 pigs), with one pig censored due to deviation in 
post-anesthetic recovery protocol and another censored 
due to failure of micro-bead delivery. No clinical signs 
of congestive heart failure were expressed by any of the 
animals during the subsequent 8-weeks. Procedural time 
was 117.5 ± 6.5 min.
Echocardiography
In all successfully infarcted pigs, left ventricular poste-
rior wall and papillary muscle motion was subjectively 
decreased on 2-D echocardiographic assessment imme-
diately following embolization (Figure  2c, d). In some 
cases, the micro-bead embolus was visualized as a hyper-
echoic amorphous region in the left ventricular posterior 
wall and anterolateral papillary muscle (see Additional 
file 1). LVEF significantly decreased from 69.7  ±  7.8% 
prior to infarction to 50.6 ± 14.7% immediately post-MI, 
and progressed to 48.7 ± 8.9% (30% decrease from base-
line) at the 8-week end-point (p = 0.011) (Figure 3a). Left 
ventricular internal diameter in systole (LVIDs) was sig-
nificantly increased from 22.6 ± 3.8 mm pre-operatively 
to 30.9 ±  5.0 mm at 8-weeks post-MI (p =  0.016) (Fig-
ure  3b). There was also an increasing trend in left ven-
tricular internal diameter during diastole (LVIDd) from 
36.2  ±  2.8  mm prior to infarction to 38.7  ±  2.9  mm 
and 40.9 ±  5.4 mm following infarction and at 8-weeks 
respectively (Figure  3b), though this parameter did not 
reach statistical significance (p  =  0.15). No significant 
changes were appreciated in other ventricular param-
eters over the allotted timeframe.
Gross evaluation and histopathology
Gross evaluation of the hearts in situ revealed a multi-
focal, pale white, firm area of infarction associated with 
the left ventricular posterior wall, midway between the 
apex and left circumflex coronary artery (Figure  4a). 
Transverse sections of the heart demonstrated mottled 
full thickness fibrosis of the left ventricular wall, and 
wall thinning associated with the infarcted region was 
observed compared to surrounding normal myocardial 
tissue (Figure 4b).
Hematoxylin and eosin-stained sections demonstrated 
a heterogenous area of fibrosis and myocytolysis, inter-
mixed with islets of intact cardiomyocytes associated with 
small arteries and arterioles (Figure  5a). Occasionally, 
micro-sphere silhouettes could be visualized obstructing 
small arteries (Figure 5b). Evaluation of Picro Sirius red-
stained slides showed a large amount of irregularly ori-
ented, perifiber collagen deposited in the infarcted region 
(Figure 5c) which was not observed in the adjacent nor-
mal myocardium (Figure 5d). Evaluation of VVG-stained 
sections revealed changes in the arterial composition 
associated with the infarcted region. Arteries were found 
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to have hyperplastic layering associated with the laminas 
media and adventitia (Figure 5e) when compared to nor-
mal arteries in unaffected myocardium (Figure 5f ).
Biochemical composition analysis
The water content of infarcted myocardium (76.30 ± 2.84%) 
was not significantly different from that of normal myocar-
dium (74.74 ± 1.82%) (p = 0.332) (Figure 6E). The collagen 
I content of infarcted myocardium (223.51 ± 111.13 µg/mg 
DW) was significantly greater than that of normal myocar-
dium (42.72 ± 14.64 µg/mg DW) (p = 0.007) (Figure 6A). 
The pyridinoline content of infarcted myocardium (1.56 × 
10−10 ±  6.93 ×  10−11  mol/mg DW) was not significantly 
different than that of normal myocardium (7.75 × 10−11 ± 
3.79 × 10−11 mol/mg DW) (p = 0.058) (Figure 6B). Pyri-
dinoline content per collagen I content was significantly 
lower in infarcted myocardium (7.38  ×  10−13  ±  2.18  × 
10−13 mol/µg) than normal myocardium (1.97 ×  10−12 ± 
1.16 ×  10−12  mol/µg) (p =  0.048) (Figure  6C). The GAG 
content of infarcted myocardium (7.84 ± 2.16 µg/mg DW) 
was significantly greater than that of normal myocardium 
(4.92 ± 0.43 µg/mg DW) (p = 0.018) (Figure 6D).
Figure 3 Changes in left ventricular ejection fraction (LVEF) and systolic internal diameter (LVIDs). LVEF decreased immediately following emboliza-
tion of the D1-LAD artery (a). This decrease in LVEF continued through the 8-week endpoint (a). At 8-weeks post-embolization LVIDs was signifi-
cantly increased compared to baseline (b). There was an apparent trend to LVIDd enlargement as well throughout the allotted timeframe.
Figure 4 Gross cardiac evaluation of infarct size and distribution. Gross cardiac evaluation at 8 weeks post-MI showed a multifocal, pale, light tan, 
firm area in the left ventricular posterior wall, midway between the apex and left circumflex coronary artery (arrows) (a). Transverse sections of the 
heart showed that the infarcted area extended into the full thickness of the myocardium with subsequent ventricular wall thinning when com-
pared to the adjacent normal myocardium (b).
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Discussion
Coronary artery disease, leading to myocardial infarc-
tion, is estimated to result in 1 of every 6 deaths in the US 
[1]. Consequently, extensive effort has been committed 
to researching methods for monitoring and treating MI, 
including the development and optimization of an animal 
model to study this disease. However, the associated high 
degree of morbidity and mortality resulting from malig-
nant ventricular arrhythmias, progression to congestive 
heart failure, and cardiogenic shock limit the utility of 
Figure 5 Histopathology of infarcted versus normal myocardium. Hematoxylin and eosin staining of representative infarcted areas demonstrated 
a heterogenous area of dense, fibrous, connective tissue intermixed with islets of intact cardiomyocytes (a). Microsphere silhouettes were visualized 
occluding small arteries and arterioles shown here as stain filling defects (b). Further evaluation with Picro Sirius stain revealed a large amount of 
disorganized collagen deposition and perifiber fibrosis in the infarcted region denoted by the deeply red staining sections (c), when compared to 
normal myocardium (d). Evaluation of VVG stained slides demonstrated hyperplasia of the arterial walls, particularly in the media and adventitial 
layers (e) when compared to normal arteries (f).
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current MI models [3, 14]. Predominant use of the dis-
tal LAD as the location of embolism likely contributes to 
the aforementioned complications, as the LAD supplies 
a large region of myocardium, including the apex, distal 
interventricular septum, and a portion of the right ventri-
cle [11, 14]. Since pigs are at elevated risk of death when 
the ischemic area is greater than 25% of the left ventri-
cle [9], and the LAD perfuses approximately 35% of the 
left ventricular mass [18], the use of the distal LAD may 
be responsible for the high mortality associated with MI 
models created via this location. Additionally, the distal 
interventricular septum and apex locations are inherently 
difficult to visualize without the use of expensive equip-
ment such as MRI [11, 14], which carries an additional 
risk of anesthetic complication and added cost. Given 
the location of the D1-LAD artery in the left ventricular 
posterior wall, a new model utilizing the D1-LAD artery 
as the site of embolism was hypothesized to restrict the 
infarct location to the left ventricular posterior wall, 
reducing the variability in infarct size and location, and 
subsequently, the number of adverse complications. Fur-
ther, the mid-left ventricular wall can be easily visualized 
using standard echocardiographic techniques, thus sub-
verting the need for more expensive and less widely avail-
able imaging modalities.
Chronic negative remodeling following acute MI is 
characterized by a progressive reduction in ventricular 
contractility and compensatory LV remodeling. Ven-
tricular myocytes in the ischemic zone undergo necrosis 
and myocytolysis, while other cells may activate caspase 
enzymes and undergo apoptosis as a result of ischemic 
injury [26]. This myocardial damage ultimately results in 
decreased systolic function with compensatory eccen-
tric hypertrophy of the surviving myocardium [27], 
ultimately manifesting as a decrease in LVEF on transtho-
racic echocardiography [28]. Studies conducted to evalu-
ate the degree with which systolic dysfunction affects 
prognosis in patients with chronic myocardial infarction 
found that the severity of contractile dysfunction, repre-
sented as a decreased LVEF, was found to be associated 
Figure 6 Biochemical composition of normal and infarcted myocardium. Collagen I content was significantly greater in infarcted myocardium than 
normal septum (A). Although pyridinoline crosslink content trended lower in the septum than the MI, the difference was not statistically significant 
(B). Pyridinoline crosslink content per collagen I content was significantly lower in infarcted myocardium than normal septum (C). Sulfated GAG 
content was significantly greater in infarcted myocardium than normal septum (D). Water content in MI was not significantly different than that in 
normal septum (E). Results plotted as mean ± standard deviation. Groups not connected by same letter are significantly different, p < 0.05 (n = 5 
per group).
Page 10 of 13Hanes et al. J Transl Med  (2015) 13:187 
with a poorer prognosis for progression to congestive 
heart failure in a non-linear fashion [28]. The impaired 
systolic function associated with embolization of the 
D1-LAD correlates well with surviving patients following 
infarction. In this model, systolic excursions of the left 
ventricular posterior wall were visibly decreased result-
ing in an immediate, statistically significant reduction in 
LVEF. Utilizing this model for MI, the LVEF was found 
to not only be reduced immediately following the acute 
ischemic insult, but continued to decline over the 8-week 
follow-up period. Alternatively, this can be contrasted 
to currently used models, which result in an immediate 
decline in LVEF followed by a rebound [18], or no signifi-
cant drop in LVEF [10]. Continued decrease in LVEF and 
systolic function through the 8-week time point suggests 
that this model resulted in a significant MI lesion, which 
continued to expand over the time course of the study. 
The 30% reduction in LVEF achieved represents a clini-
cally relevant lesion size for studying and evaluating MI. 
Critically, lesion size was also consistently small enough 
to avoid the complications associated with heart failure 
or arrhythmogenesis. Through utilization of the D1-LAD 
artery as the site of embolism, this model was able to pro-
duce a clinically relevant reduction in systolic function 
that mimics that found in the naturally occurring disease, 
while keeping the lesion confined to a size that did not 
result in high morbidity or mortality.
In concert with decreasing systolic function, ventricu-
lar remodeling results in chamber dilation and eccentric 
hypertrophy [28]. Decreased systolic function follow-
ing acute MI activates neurohumoral mechanisms, such 
as locally produced angiotensin converting enzyme 
and increased production of angiotensin II [26]. These 
enzymes initially intended to restore cardiac perfor-
mance, ultimately result in negative remodeling of the 
myocardial ECM. This phenomenon, combined with 
eccentric hypertrophy of the surviving myocardium, 
results in chamber dilation and progressive impairment 
in systolic function [28]. These changes can be quan-
tified via transthoracic echocardiography of left ven-
tricular diameter, with progressive increases in LVIDs 
representing progressive contractile dysfunction and pro-
gressive increases in LVIDd representing chamber dila-
tion. In studies evaluating negative prognostic indicators 
in patients with chronic myocardial infarction, progres-
sive increases in left ventricular end-systolic volume have 
been correlated with poorer prognosis for progression to 
heart failure [29]. Indeed, in the D1-LAD model, LVIDs 
immediately increased following infarction, most likely 
as a result of stunned myocardium and decreased systolic 
function (Figure 3) following MI. The increase in LVIDs 
progressed over the 8-week study period showing sus-
tained and progressive systolic dysfunction utilizing this 
model. Additionally, there was a trend toward increased 
LVIDd, representing mild chamber dilation over the 
course of the study even though this value failed to reach 
statistical significance. These changes in chamber size 
are presumably a consequence of the same adverse car-
diac remodeling that has been described in humans [28]. 
The acute and chronic changes in myocardial function 
demonstrated in this study indicate that D1-LAD embo-
lism results in a clinically relevant MI lesion with sub-
sequent chronic remodeling that mimic human cardiac 
pathophysiology.
Following initial necrosis and myocytolysis, functional 
myocardium is replaced with heterogeneous collagen 
deposition and myofibroblast differentiation [30]. Dur-
ing acute ischemic injury, necrosis and apoptosis result 
in sub-acute and acute cardiomyocyte death, respectively. 
Following injury, the cells release signaling factors and 
cytokines that ultimately result in stimulation of neutro-
phils and mononuclear cells [26]. Glycosaminoglycans 
within the ECM facilitate the recruitment of peripheral 
mononuclear cells by sequestering secreted chemokines 
[31]. This sterile inflammation results in removal of the 
damaged myocardial tissue. Subsequent healing of the 
myocardium is initiated with the stimulation of fibro-
blast proliferation and collagen deposition. This scar tis-
sue is ultimately less functional contributing to decreases 
in contractility and increasing wall stress [28]. Humans 
with coronary artery disease have been shown to have 
increased perifiber fibrosis and perivascular fibrosis asso-
ciated with the ischemia found with chronic coronary 
disease [30]. The D1-LAD MI model resulted in a mot-
tled distribution of infarcted tissue in the LV posterior 
wall similar to that found in human patients when evalu-
ated via histopathology. On both H&E and Picro Sirius 
red-stained slides, myocytolysis had been replaced with 
fibrosis interspersed with islets of intact cardiomyocytes. 
Indeed, collagen content of the infarct zone was fivefold 
greater than that of the septum. In patients with end-
stage heart failure following MI, collagen content of the 
scar region was approximately tenfold greater than that 
of a remote region [32]. Although pyridinoline crosslink 
content in the infarct zone was not significantly differ-
ent than that in the septum, the proportion of pyridino-
line crosslinks per collagen was two to threefold less in 
infarcted myocardium than in the septum, suggesting 
that the collagen associated with the infarct scar was 
newly synthesized [33] as a result of the chronic negative 
remodeling following MI. Additionally, the slight eleva-
tion in sulfated GAG content of infarcted myocardium 
above that of septum has been observed following MI by 
embolization of the D1-LAD. These changes to the ECM 
in infarcted myocardium correlate well with the changes 
that occur in humans with chronic myocardial infarctions 
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where myofibers have been replaced with newly depos-
ited immature collagen [30, 34].
Utilizing the D1-LAD artery, monitoring of the infarct 
location and left ventricular parameters was possible 
via transthoracic echocardiography, a preferred alterna-
tive to more time consuming and expensive methods. 
Distribution of the LAD territory in the apical region 
is difficult to visualize via echocardiography, requiring 
expensive and less widely available imaging modalities. 
MRI [14] or Tc-SPECT [11] have traditionally been used 
for monitoring infarct distribution and cardiac func-
tion following occlusion of the LAD. Unfortunately, pigs 
undergoing these modalities must undergo anesthesia 
for the duration of the scan which is associated with an 
additional inherent risk. These methodologies are also 
less widely available, more cost prohibitive, and require 
longer scan times than transthoracic echocardiography. 
In this study, all subjects successfully underwent tran-
sthoracic echocardiography with subsequent chronic 
monitoring for systolic function and chamber dilation. 
The lesion location in the left ventricular posterior wall 
formed by embolization of the D1-LAD resulted in 
an embolus location that could be directly visualized 
in the left ventricular posterior wall (see Additional 
file 1). Changes on echocardiographic evaluation cor-
related well with post-mortem findings when evaluat-
ing the heart grossly. This is in contrast to other studies 
that have shown interventricular septal involvement 
and right ventricular involvement, with subsequent 
wall thinning through utilization of the distal LAD [8, 
14]. Utilization of the D1-LAD artery appears to have 
restricted the area of infarction to the left ventricular 
posterior wall, resulting in a less variable and dispersed 
infarct region that still produced a clinically relevant 
lesion. Furthermore, the developed D1-LAD emboliza-
tion methodology was able to create an infarction that 
could be directly visualized, as well as chronically moni-
tored for progressive systolic dysfunction and chamber 
dilation, via standard echocardiography.
Development of malignant ventricular arrhythmias 
causing acute mortality in study subjects has been the 
most commonly reported complication associated with 
previously reported porcine MI models [3, 9, 15, 35]. Pre-
viously reported LAD occlusion methods resulted in up 
to 50% [36] procedural attrition rates due to the develop-
ment of ventricular arrhythmias or cardiogenic shock. 
The 17% procedural attrition rate with the developed 
D1-LAD embolization method was due to an arterial 
dissection upon catheterization of the D1-LAD artery, 
though it is unclear as to whether this lesion is specific 
to D1-LAD access, or if such a lesion could occur in 
any procedure in which catheterization of the LAD is 
required. Although occasional premature ventricular 
contractions were detected during these procedures, 
none of the subjects were lost due to the development of 
malignant ventricular arrhythmias. Therefore, the devel-
oped D1-LAD embolization method results in a low 
mortality rate, with minimal production of intraoperative 
ventricular arrhythmias.
Although this methodology appears to have signifi-
cant utility for research in chronic myocardial infarc-
tions, it is recognized that several study limitations 
exist. Firstly, catheterization of the D1-LAD artery is 
somewhat more technically challenging than engaging 
the distal LAD, requiring greater procedural time and 
experience to execute. Subsequently, longer anesthetic 
times and greater risk for complications such anes-
thetic related complications or arterial dissection may 
be of higher potential with this procedure than previ-
ously reported methods. Additionally, the procedure 
was most successfully performed in pigs >50  kg where 
the D1-LAD artery was large enough to be consist-
ently engaged without delay (data not shown). Lastly, 
embolism in one subject was unsuccessful due to clot 
formation in the instrumentation, highlighting the 
importance of adequate anticoagulant therapy for suc-
cessful bead deployment. In spite of these limitations, 
embolization of the D1-LAD artery represents a good 
model for clinical research.
Conclusions
The porcine chronic MI model using embolization of 
the D1-LAD described here appears to be a clinically 
relevant recreation of the functional, architectural, and 
biochemical changes that occur following ischemic insult 
in humans. Additionally, the location of the embolism 
created with this method permits visualization of the 
MI lesion and monitoring of left ventricular structure 
and function via widely available imaging modalities in 
non-anesthetized animals. In the current study, the area 
of infarction was isolated to the left ventricular wall, 
and easily visible via standard transthoracic echocardi-
ography. Gross and histopathologic lesion distribution 
were found to be heterogenous and representative of 
the pathology clinically documented in human patients 
with chronic MI. Our findings in this study support a 
new methodology of creating MI lesion in porcine mod-
els which can be easily monitored via echocardiography 
and closely mimics the pathophysiology associated with 
human MI patients.
Additional file
Additional File 1.  Left ventricular short axis echocardiographic video 
loop following embolization (.avi). The location of the infarct can be 
directly visualized as an amorphous, hyperechoic area associated with the 
anterolateral papillary muscle and left ventricular wall.
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